Be in the know. 15 key reads for Thursday…

  1. The Fed will be growing its balance sheet again, but don’t call it ‘QE4’ (CNBC)
  2. James Bullard says the Fed still has a ‘little more to go’ with rate cuts (CNBC)
  3. Hedge Fund and Insider Trading News: Tiger Global Management, Elliott Management, Aldeyra Therapeutics Inc (ALDX), Restoration Hardware Holdings, Inc (RH), and More (Insider Monkey)
  4. Drug-Price Legislation Unlikely Before Election, Analyst Says (Barron’s)
  5. China says in close communication with U.S. over October trade talks (Reuters)
  6. Netflix Stock Has Taken a Beating. Here’s How to Play a Bounceback. (Barron’s)
  7. Trump Announces a Trade Pact With Japan (New York Times)
  8. Latinos may be the key to future US economic growth, study argues (CNBC)
  9. AbbVie Is Up After Another Analyst Reconsidered Its Allergan Acquisition and Upgraded the Stock (Barron’s)
  10. Wells Fargo acting chief Parker likely to get job by default (Yahoo! Finance)
  11. Despite Setbacks, Biogen is a Buy for Value Investors (Yahoo! Finance)
  12. 4 Blue-Chip Large-Cap Stocks That All Yield a Massive 7% or More (24/7 Wall Street)
  13. Millennials Continue to Leave Big Cities (Wall Street Journal)
  14. Trump Says Impeachment Could Derail U.S.-Mexico-Canada Trade Deal (Wall Street Journal)
  15. An Unimpeachable Reason to Buy Stocks (Wall Street Journal)

 

 

Be in the know. 7 key reads for Wednesday…

  1. How Pelosi’s impeachment inquiry into Trump could be a plus for one stock sector (MarketWatch)
  2. Metals billionaire Andrew Forrest is making a $300 million bet on the next big commodity — plastic (MarketWatch)
  3. What Trump’s Impeachment Inquiry Means for the Stock Market (Barron’s)
  4. McDonald’s CEO Wants Big Macs to Keep Up With Big Tech (Bloomberg)
  5. Trump’s Fed tweets pull interest-rate expectations lower, new study finds (Business Insider)
  6. Explainer: Trade deal in focus as Trump, Japan’s Abe head for summit (Reuters)
  7. 7 Value Stocks With Double-Digit Revenue Growth (Yahoo! Finance)